Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1157]

Fundamental discoveries for prostate cancer in Sub-Saharan Africa: The MADCaP...

Dr Timothy Rebbeck - Harvard University and Dana-Farber Cancer Institute...

Fundamental discoveries for prostate cancer in Sub-Saharan Africa: The MADCaP network ( Dr Timothy Rebbeck - Harvard University and Dana-Farber Cancer Institute, Boston, USA )

Top 10 choosing wisely genitourinary cancers

Dr Amandeep Arora - Tata memorial centre, Mumbai, India

Top 10 choosing wisely genitourinary cancers ( Dr Amandeep Arora - Tata memorial centre, Mumbai, India )

Molecular profiling in prostate cancer: key challenges for clinical...

Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain

Molecular profiling in prostate cancer: key challenges for clinical implementation ( Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain )

Intraoperative Radiotherapy

Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal

Intraoperative Radiotherapy ( Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal )

Cancer survivors' stories: An African perspective

Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation

Cancer survivors' stories: An African perspective ( Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation )

Potential for enfortumab vedotin plus pembrolizumab in cisplatin-ineligible...

Prof Jonathan E Rosenberg - Memorial Sloan Kettering Cancer Center, New York...

Potential for enfortumab vedotin plus pembrolizumab in cisplatin-ineligible locally advanced or metastatic urothelial cancer ( Prof Jonathan E Rosenberg - Memorial Sloan Kettering Cancer Center, New York City, USA )

ESMO 2022: Highlights, commentary and analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2022: Highlights, commentary and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Updates in prostate cancer from ESMO 2022

Prof Eleni Efstathiou, Prof Gerhardt Attard and Prof Boris Hadaschik

Updates in prostate cancer from ESMO 2022 ( Prof Eleni Efstathiou, Prof Gerhardt Attard and Prof Boris Hadaschik )

Latest in mRCC from ESMO 2022

Dr Javier Puente, Dr Bernard Escudier, Prof Viktor Grünwald and Prof Stéphane...

Latest in mRCC from ESMO 2022 ( Dr Javier Puente, Dr Bernard Escudier, Prof Viktor Grünwald and Prof Stéphane Oudard )

ESMO 2022: Renal roundup

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

ESMO 2022: Renal roundup ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Emerging systemic therapies in rare urothelial cancer variants

Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA

Emerging systemic therapies in rare urothelial cancer variants ( Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA )

Lenvatinib plus pembro for aRCC - update on the CLEAR study

Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA

Lenvatinib plus pembro for aRCC - update on the CLEAR study ( Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer